While brain shrinkage is known to occur in everyone because of ageing-related cognitive decline, excess brain shrinkage has ...

The brain has a waste-disposal system that clears away junk proteins that contribute to the development of dementia and ...

Sage Therapeutics said on Tuesday it will discontinue the development of its Alzheimer's disease drug as it did not meet the ...

The brain has a waste-disposal system that clears away junk proteins that contribute to the development of dementia an ...

Sage has decided to discontinue the development of dalzanemdor in Alzheimer’s disease. A study of the candidate in Huntington ...

Sage Therapeutics has seen another clinical trial go up in smoke. | Sage Therapeutics has seen another clinical trial go up ...

Saturday marked the 16th year for the Walk to End Alzheimer’s here in Victoria, however, the fight for the disease has been ...

Microglia are the brain's resident immune cells. Their job is to patrol the brain's blood vessels looking for invading ...

Sage Therapeutics does not plan further clinical development of its dalzanemdor drug candidate in Alzheimer's disease following its failure in a mid-stage study.

Muscae volitantes — “eye floaters” are those little, transparent threads that you see floating across your eyeball. Generally ...

(RTTNews) - Sage Therapeutics, Inc. (SAGE) Tuesday said its Phase 2 LIGHTWAVE study to evaluate dalzanemdor in participants with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's ...

Sage Therapeutics said on Tuesday it would discontinue the development of its experimental drug for Alzheimer's disease as it ...